Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 175 participants.
Also called NCT02522481
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 175 participants
- Sponsor
- Registry
-
NCT02522481
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Germany, Italy
- Registry status
- Completed
Technical summary
Registry record NCT02522481. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-09-24 (actual); primary completion 2017-11-07 (actual). Results posted on 2020-08-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Lumason
- Lead sponsor
- Bracco Diagnostics, Inc
Record details
- Record id
cardio:ct-nct02522481- Content hash
c5d1de54e76161f79838d510676b5260687b6c8f6fb906ae93d1f00211c3f0fe